Tirdzniecība Outset Medical, Inc. - OM CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.08 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.025457% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | 0.003235% | ||||||||
Nakts laika nodeva | 21:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | USD | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | United States of America | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Outset Medical Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Iepriekš. aizvērt* | 20.8 |
Atvērt* | 20.61 |
Izmaiņas par 1 gadu* | -5.42% |
Dienas Diapazons* | 20.61 - 22.02 |
52 ned Diapazons | 11.41-30.55 |
Vidējais apjoms (10 dienas) | 404.61K |
Vidējais apjoms (3 mēneši) | 10.94M |
Tirgus Kapitalizācija | 1.05B |
Cenas/Peļņas Attiecība | -100.00K |
Izvietotās Akcijas | 49.23M |
Ieņēmumi | 118.29M |
EPS | -3.51 |
Dividende (Ienesīgums %) | N/A |
Beta | -100.00K |
Nākamās Peļņas Datums | Jul 31, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
May 31, 2023 | 20.83 | -0.22 | -1.05% | 21.05 | 21.21 | 20.24 |
May 30, 2023 | 21.22 | -0.08 | -0.38% | 21.30 | 21.67 | 20.71 |
May 26, 2023 | 21.38 | 1.76 | 8.97% | 19.62 | 21.41 | 19.48 |
May 25, 2023 | 20.20 | 0.23 | 1.15% | 19.97 | 20.26 | 19.47 |
May 24, 2023 | 20.30 | 0.77 | 3.94% | 19.53 | 20.49 | 19.47 |
May 23, 2023 | 20.13 | -1.50 | -6.93% | 21.63 | 22.29 | 19.73 |
May 22, 2023 | 22.06 | 1.31 | 6.31% | 20.75 | 22.32 | 20.74 |
May 19, 2023 | 21.18 | 0.19 | 0.91% | 20.99 | 21.76 | 20.99 |
May 18, 2023 | 21.03 | 1.50 | 7.68% | 19.53 | 21.14 | 19.47 |
May 17, 2023 | 20.08 | 0.10 | 0.50% | 19.98 | 20.22 | 19.51 |
May 16, 2023 | 20.14 | 0.37 | 1.87% | 19.77 | 20.17 | 19.48 |
May 15, 2023 | 20.11 | 0.09 | 0.45% | 20.02 | 20.32 | 19.61 |
May 12, 2023 | 19.98 | 0.01 | 0.05% | 19.97 | 20.28 | 19.62 |
May 11, 2023 | 20.15 | -0.54 | -2.61% | 20.69 | 20.94 | 19.80 |
May 10, 2023 | 20.87 | 0.59 | 2.91% | 20.28 | 20.99 | 20.21 |
May 9, 2023 | 20.26 | 0.50 | 2.53% | 19.76 | 20.49 | 19.19 |
May 8, 2023 | 19.93 | -0.09 | -0.45% | 20.02 | 20.24 | 18.24 |
May 5, 2023 | 20.79 | -0.18 | -0.86% | 20.97 | 22.48 | 20.79 |
May 4, 2023 | 20.92 | 2.45 | 13.26% | 18.47 | 21.52 | 18.47 |
May 3, 2023 | 20.28 | 0.95 | 4.91% | 19.33 | 20.46 | 19.12 |
Outset Medical, Inc. Events
Laiks (UTC) (UTC) | Valsts | Notikums |
---|---|---|
Monday, July 31, 2023 | ||
Laiks (UTC) (UTC) 10:59 | Valsts US
| Notikums Q2 2023 Outset Medical Inc Earnings Release Q2 2023 Outset Medical Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Laiks (UTC) (UTC) 10:59 | Valsts US
| Notikums Q3 2023 Outset Medical Inc Earnings Release Q3 2023 Outset Medical Inc Earnings ReleaseForecast -Previous - |
- Ikgadējs
- Ceturkšņa
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kopējie ienākumi | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
Ienākumi | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
Cost of Revenue, Total | 97.542 | 94.994 | 62.972 | 32.88 | 8.122 |
Bruto Peļņa | 17.833 | 7.608 | -13.037 | -17.802 | -6.115 |
Kopējie Darbības Izdevumi | 277.761 | 233.121 | 168.969 | 85.385 | 48.57 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 129.997 | 101.386 | 75.58 | 29.178 | 17.532 |
Pētniecība un Attīstība | 48.855 | 36.741 | 28.85 | 23.327 | 22.916 |
Darbības Izdevumi | -162.386 | -130.519 | -119.034 | -70.307 | -46.563 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -0.275 | -1.217 | -2.365 | -1.772 | -2.93 |
Citi, Neto | 0 | 0 | -0.093 | 3.8 | -0.262 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -162.661 | -131.736 | -121.492 | -68.279 | -49.755 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
Neto Ienākumi | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
Total Adjustments to Net Income | 0 | 42.168 | -17.163 | -23.3 | |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
Atšķaidītie Neto Ienākumi | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
Atšķaidītie Ienākumi par Akcijām | 48.161 | 45.589 | 42.722 | 45.2225 | 45.2225 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -3.38357 | -2.89401 | -1.85675 | -1.88981 | -1.61601 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Atšķaidītā Normalizētā Peļņa par Akciju | -3.36512 | -2.89401 | -1.82007 | -1.88981 | -1.61601 |
Neparedzēti Izdevumi (Ienākumi) | 1.367 | 0 | 1.567 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kopējie ienākumi | 33.467 | 32.007 | 27.761 | 25.057 | 30.55 |
Ienākumi | 33.467 | 32.007 | 27.761 | 25.057 | 30.55 |
Cost of Revenue, Total | 27.039 | 26.734 | 23.425 | 21.275 | 26.108 |
Bruto Peļņa | 6.428 | 5.273 | 4.336 | 3.782 | 4.442 |
Kopējie Darbības Izdevumi | 76.952 | 73.198 | 68.76 | 68.778 | 67.025 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 36.12 | 33.653 | 32.276 | 33.982 | 30.086 |
Pētniecība un Attīstība | 13.793 | 11.444 | 13.059 | 13.521 | 10.831 |
Darbības Izdevumi | -43.485 | -41.191 | -40.999 | -43.721 | -36.475 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -0.294 | -0.189 | 0.238 | -0.022 | -0.302 |
Citi, Neto | 0 | ||||
Neto Ienākumi Pirms Nodokļu Nomaksas | -43.779 | -41.38 | -40.761 | -43.743 | -36.777 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Neto Ienākumi | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Total Adjustments to Net Income | |||||
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Atšķaidītie Neto Ienākumi | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Atšķaidītie Ienākumi par Akcijām | 48.783 | 49.139 | 48.129 | 47.882 | 47.487 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.90136 | -0.8434 | -0.84733 | -0.91556 | -0.77689 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | -0.90136 | -0.82532 | -0.84733 | -0.91556 | -0.77689 |
Neparedzēti Izdevumi (Ienākumi) | 1.367 |
- Ikgadējs
- Ceturkšņa
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 373.645 | 409.802 | 345.911 | 79.646 | 147.646 |
Nauda un Īstermiņa Ieguldījumi | 287.502 | 339.488 | 314.87 | 69.378 | 142.782 |
Nauda un Ekvivalenti | 73.222 | 182.348 | 294.972 | 36.226 | 33.264 |
Īstermiņa Ieguldījumi | 214.28 | 157.14 | 19.898 | 33.152 | 109.518 |
Debitoru Parādu Kopsumma, Neto | 28.07 | 25.6 | 6.468 | 3.914 | 1.088 |
Accounts Receivable - Trade, Net | 28.07 | 25.6 | 6.468 | 3.914 | 1.088 |
Total Inventory | 51.476 | 39.185 | 18.384 | 4.596 | 3.022 |
Prepaid Expenses | 6.597 | 5.529 | 6.189 | 1.058 | 0.754 |
Total Assets | 400.115 | 463.464 | 403.829 | 88.366 | 151.13 |
Property/Plant/Equipment, Total - Net | 21.993 | 20.195 | 23.251 | 7.895 | 2.926 |
Property/Plant/Equipment, Total - Gross | 32.8 | 27.849 | 28.239 | 10.565 | 5.149 |
Accumulated Depreciation, Total | -10.807 | -7.654 | -4.988 | -2.67 | -2.223 |
Other Long Term Assets, Total | 4.477 | 33.467 | 34.667 | 0.825 | 0.558 |
Total Current Liabilities | 51.949 | 51.695 | 36.692 | 24.91 | 10.213 |
Accounts Payable | 0.603 | 1.763 | 4.948 | 4.96 | 3.373 |
Accrued Expenses | 35.575 | 39.575 | 26.578 | 10.43 | 5.349 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 7.509 | 0.01 | ||
Other Current Liabilities, Total | 15.771 | 10.357 | 5.166 | 2.011 | 1.481 |
Total Liabilities | 154.125 | 89.383 | 75.22 | 51.107 | 46.796 |
Total Long Term Debt | 96.336 | 29.762 | 29.674 | 21.561 | 28.355 |
Long Term Debt | 96.336 | 29.762 | 29.674 | 21.561 | 28.346 |
Capital Lease Obligations | 0 | 0.009 | |||
Other Liabilities, Total | 5.84 | 7.926 | 8.854 | 4.636 | 8.228 |
Total Equity | 245.99 | 374.081 | 328.609 | 37.259 | 104.334 |
Redeemable Preferred Stock | 0 | 0 | 0 | 409.446 | 392.284 |
Common Stock | 0.048 | 0.047 | 0.043 | 0.007 | 0.006 |
Additional Paid-In Capital | 1035.46 | 1000.21 | 822.624 | 0.356 | 0 |
Retained Earnings (Accumulated Deficit) | -788.95 | -625.994 | -494.059 | -372.572 | -287.896 |
Unrealized Gain (Loss) | -0.564 | -0.184 | 0.001 | 0.022 | -0.06 |
Total Liabilities & Shareholders’ Equity | 400.115 | 463.464 | 403.829 | 88.366 | 151.13 |
Total Common Shares Outstanding | 48.465 | 47.241 | 42.722 | 45.2225 | 45.2225 |
Other Current Assets, Total | 0.7 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 337.275 | 373.645 | 310.003 | 345.777 | 377.426 |
Nauda un Īstermiņa Ieguldījumi | 249.213 | 287.502 | 227.517 | 262.062 | 302.267 |
Nauda un Ekvivalenti | 36.386 | 73.222 | 63.877 | 75.497 | 114.346 |
Īstermiņa Ieguldījumi | 212.827 | 214.28 | 163.64 | 186.565 | 187.921 |
Debitoru Parādu Kopsumma, Neto | 34.314 | 28.07 | 22.512 | 24.627 | 26.899 |
Accounts Receivable - Trade, Net | 34.314 | 28.07 | 22.512 | 24.627 | 26.899 |
Total Inventory | 47.733 | 51.476 | 55.26 | 53.689 | 42.873 |
Prepaid Expenses | 6.015 | 6.597 | 4.714 | 5.399 | 5.387 |
Total Assets | 362.665 | 400.115 | 365.722 | 401.236 | 431.742 |
Property/Plant/Equipment, Total - Net | 21.012 | 21.993 | 22.022 | 21.932 | 20.844 |
Other Long Term Assets, Total | 4.378 | 4.477 | 33.697 | 33.527 | 33.472 |
Total Current Liabilities | 44.268 | 51.949 | 49.644 | 55.24 | 48.89 |
Accounts Payable | 1.988 | 0.603 | 1.444 | 2.753 | 5.149 |
Accrued Expenses | 27.957 | 35.575 | 34.041 | 36.973 | 30.789 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 14.323 | 15.771 | 14.159 | 14.514 | 12.952 |
Total Liabilities | 146.379 | 154.125 | 86.619 | 91.472 | 86.289 |
Total Long Term Debt | 96.48 | 96.336 | 29.828 | 28.806 | 29.784 |
Long Term Debt | 96.48 | 96.336 | 29.828 | 28.806 | 29.784 |
Other Liabilities, Total | 5.631 | 5.84 | 7.147 | 7.426 | 7.615 |
Total Equity | 216.286 | 245.99 | 279.103 | 309.764 | 345.453 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.049 | 0.048 | 0.048 | 0.048 | 0.048 |
Additional Paid-In Capital | 1049.27 | 1035.46 | 1027.49 | 1017.4 | 1008.94 |
Retained Earnings (Accumulated Deficit) | -832.921 | -788.95 | -747.506 | -706.725 | -662.886 |
Unrealized Gain (Loss) | -0.113 | -0.564 | -0.934 | -0.955 | -0.649 |
Total Liabilities & Shareholders’ Equity | 362.665 | 400.115 | 365.722 | 401.236 | 431.742 |
Total Common Shares Outstanding | 49.216 | 48.465 | 48.295 | 47.997 | 47.712 |
Current Port. of LT Debt/Capital Leases | 1 | ||||
Property/Plant/Equipment, Total - Gross | 32.8 | ||||
Accumulated Depreciation, Total | -10.807 |
- Ikgadējs
- Ceturkšņa
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
Nauda no Darbības | -145.729 | -130.264 | -99.015 | -70.292 | -46.442 |
Nauda no Darbības | 5.169 | 5.162 | 3.159 | 1.484 | 1.069 |
Bezskaidras Naudas Preces | 33.2 | 22.112 | 25.167 | -1.878 | 2.486 |
Cash Taxes Paid | 0.385 | 0.083 | 0.019 | 0.035 | 0.009 |
Izmaiņas Apgrozāmajā Kapitālā | -21.142 | -25.603 | -5.849 | -1.599 | -0.217 |
Nauda no Ieguldījumu Darbībām | -66.295 | -142.507 | 3.947 | 74.297 | -68.776 |
Kapitālie Izdevumi | -8.325 | -3.108 | -9.108 | -3.293 | -1.766 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -57.97 | -139.399 | 13.055 | 77.59 | -67.01 |
Nauda no Darbībām ar Finansēšanu | 72.898 | 160.147 | 385.682 | 0.249 | 134.872 |
Naudas Plūsma Finansēšanas Posteņos | -0.181 | 0 | |||
Akciju Izsniegšana (Atkāpšanās), Neto | 8.042 | 160.147 | 387.046 | 0.439 | 134.881 |
Parādu Izsniegšana (Atkāpšanās), Neto | 64.856 | 0 | -1.364 | -0.009 | -0.009 |
Neto Izmaiņas Naudā | -139.126 | -112.624 | 290.614 | 4.254 | 19.654 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -43.971 | -162.956 | -121.512 | -80.731 | -36.892 |
Cash From Operating Activities | -44.756 | -145.729 | -111.222 | -76.91 | -38.335 |
Cash From Operating Activities | 1.384 | 5.169 | 3.9 | 2.586 | 1.262 |
Non-Cash Items | 8.598 | 33.2 | 23.826 | 15.118 | 6.581 |
Cash Taxes Paid | 0.201 | 0.385 | 0.334 | 0.283 | 0.205 |
Changes in Working Capital | -10.767 | -21.142 | -17.436 | -13.883 | -9.286 |
Cash From Investing Activities | 2.643 | -66.295 | -14.547 | -34.706 | -33.39 |
Capital Expenditures | -0.81 | -8.325 | -6.216 | -3.475 | -1.478 |
Other Investing Cash Flow Items, Total | 3.453 | -57.97 | -8.331 | -31.231 | -31.912 |
Cash From Financing Activities | 5.277 | 72.898 | 7.298 | 4.765 | 3.723 |
Issuance (Retirement) of Stock, Net | 5.277 | 8.042 | 7.433 | 4.765 | 3.723 |
Issuance (Retirement) of Debt, Net | 64.856 | ||||
Net Change in Cash | -36.836 | -139.126 | -118.471 | -106.851 | -68.002 |
Financing Cash Flow Items | -0.135 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
Fidelity Management & Research Company LLC | Investment Advisor | 14.77 | 7270972 | 49376 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.4572 | 4655616 | 82430 | 2023-03-31 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 6.6916 | 3294148 | -225722 | 2023-03-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.2155 | 3059782 | -77314 | 2023-03-31 | LOW |
Bellevue Asset Management AG | Investment Advisor | 5.9047 | 2906759 | 63080 | 2023-03-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 5.5577 | 2735954 | 169738 | 2023-03-31 | LOW |
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 3.8619 | 1901126 | 91339 | 2023-03-31 | LOW |
Champlain Investment Partners, LLC | Investment Advisor | 3.7109 | 1826825 | -33580 | 2023-03-31 | LOW |
Braidwell LP | Hedge Fund | 3.5637 | 1754350 | 49798 | 2023-03-31 | HIGH |
Mubadala Investment Company PJSC | Sovereign Wealth Fund | 2.9346 | 1444665 | -1445678 | 2021-12-07 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.6458 | 1302457 | 129782 | 2023-03-31 | LOW |
Eagle Health Investments LP | Hedge Fund | 2.4384 | 1200385 | -20224 | 2023-03-31 | MED |
Perceptive Advisors LLC | Private Equity | 2.213 | 1089427 | 0 | 2023-03-31 | MED |
C WorldWide Asset Management Fondsmaeglerselskab A/S | Investment Advisor | 2.0314 | 1000000 | 0 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8701 | 920601 | 35123 | 2023-03-31 | LOW |
Pura Vida Investments, LLC | Hedge Fund | 1.8671 | 919136 | 464746 | 2023-03-31 | HIGH |
RTW Investments L.P. | Investment Advisor/Hedge Fund | 1.6427 | 808658 | -100994 | 2023-03-31 | LOW |
Columbia Wanger Asset Management, LLC | Investment Advisor | 1.4124 | 695303 | 157420 | 2023-03-31 | MED |
Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.2327 | 606819 | -3405 | 2023-03-31 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 1.1932 | 587411 | -16224 | 2023-03-31 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group535K+
Tirgotāji
87K+
Ikmēneša aktīvie klienti
$113M+
Ikmēneša ieguldījumu apjoms
$64M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Outset Medical, Inc. Company profile
Par Outset Medical, Inc.
Outset Medical, Inc. ir medicīnas tehnoloģiju uzņēmums, kas piedāvā Tablo. Tablo ir mobils integrēts hemodialīzes risinājums akūtai un mājas hemodialīzes terapijai. Integrētā ūdens attīrīšana un dializāta ražošana pēc pieprasījuma ļauj Tablo kalpot kā dialīzes klīnika uz riteņiem un ļauj pakalpojumu sniedzējiem piekļūt vienotai platformai no slimnīcas līdz pat mājām. Tablo kārtridžs ir vienreiz lietojams palīgmateriāls, kas paredzēts, lai atvieglotu ekstrakorporālo asins attīrīšanu pacientiem, un sastāv no iepriekš konfigurētas asins, fizioloģiskā šķīduma un infūzijas caurules. Tablo skārienekrāna panelis ļauj lietotājam orientēties ārstēšanā, izmantojot animācijas un netehnisku valodu, kas pielāgota gan profesionāliem, gan neprofesionāliem lietotājiem. Tablo mākoņa savienojamības programmatūra nodrošina iekārtas diagnostikas un analītikas ekosistēmu, ārstēšanas instrukcijas, uzraudzību un ziņošanu, uzlabotu dokumentāciju un attālinātu iekārtas pārvaldību. Turklāt Tablo nodrošina arī stabilu klīnisko aprūpi.
Industry: | Advanced Medical Equipment & Technology (NEC) |
3052 Orchard Drive
SAN JOSE
CALIFORNIA 95134
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 535 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com